Emerald Mutual Fund Advisers Trust’s Oric Pharmaceuticals ORIC Stock Holding History

Emerald Mutual Fund Advisers Trust’s Portfolio ORIC Stock Details ORIC Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2021 Q4	–	Sell	-742,666	Closed	-$15.5M	–	228
2021 Q3	$15.5M	Buy	742,666 +185,456	+33%	+$3.76M	0.54%	67
2021 Q2	$9.86M	Sell	557,210 -67,000	-11%	-$1.47M	0.32%	106
2021 Q1	$15.3M	Buy	624,210 +135,976	+28%	+$4.3M	0.51%	85
2020 Q4	$16.5M	Buy	488,234 +175,751	+56%	+$5.04M	0.58%	74
2020 Q3	$7.82M	Buy	312,483 +143,315	+85%	+$3.41M	0.35%	87
2020 Q2	$5.71M	Buy	+169,168	New	+$5.4M	0.27%	107

Other funds holding ORIC

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Column Group San Francisco, California $101M AUM 290.34% 1-Year Est. Return

EcoR1 Capital San Francisco, California $2.36B AUM 204.53% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

OrbiMed New York $5.05B AUM 125.28% 1-Year Est. Return

ACH

ArrowMark Colorado Holdings Denver, Colorado $3.76B AUM 21.77% 1-Year Est. Return

Victory Capital Management San Antonio, Texas $156B AUM 27.51% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Alkeon Capital Management New York $59.5B AUM 51.63% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Emerald Mutual Fund Advisers Trust's ORIC Position: Q4 2021 in Review

Emerald Mutual Fund Advisers Trust sold out of Oric Pharmaceuticals (ORIC) in Q4 2021, closing a stake of 742,666 shares — an estimated $15.5M sold.

Emerald Mutual Fund Advisers Trust first reported a position in ORIC in Q2 2020 and held it in 6 quarters. The position peaked at $16.5M in Q4 2020. 80 funds tracked by Wall St. Rank hold ORIC as of Q4 2021.

Emerald Mutual Fund Advisers Trust reported no remaining Oric Pharmaceuticals position as of Q4 2021 after selling out during the quarter.
Emerald Mutual Fund Advisers Trust sold 742,666 Oric Pharmaceuticals shares in Q4 2021, an estimated $15.5M.
Emerald Mutual Fund Advisers Trust first reported a position in Oric Pharmaceuticals in Q2 2020 and held it in 6 quarters.
Emerald Mutual Fund Advisers Trust's Oric Pharmaceuticals position peaked at $16.5M in Q4 2020.
80 funds tracked by Wall St. Rank held Oric Pharmaceuticals as of Q4 2021.

Based on Emerald Mutual Fund Advisers Trust's 13F filing for Q4 2021, filed 2 Feb 2022.